retatrutide clinical trials duration Significantly Reduces Visceral Fat in Lilly's triple agonist, retatrutide, delivered

doi: 10.1093/rheumatology/kes242

EGCG reduced cisplatin-induced ROS generation and ERK1/2 and STAT1 activity, but retained STAT3 and Bcl-xL activity, allowing cisplatin to continue its anti-tumour effects ( Epicatechin (EC) is a minor component of green tea

Samples were randomly assigned to control or experimental groups, and the investigators were blinded to the experimental conditions

(Note: Compounded GLP1s are not FDA-approved and thus might not be as rigorously monitored for safety, quality, or efficacy

Independent third-party reviews: Anyone can make claims online

People who have preferences like following a vegan diet may also need special consideration, as they can also be on GLP-1 medications